尽管持续使用甲磺酸伊马替尼治疗且持续完全缓解，但FIP1L1-PDGFRα阳性嗜酸性粒细胞增多综合征仍发生了吕弗勒心内膜炎。 - Suppr

Suppr

超能文献

Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.

作者信息

Václavík Jan, Szotkowski Tomás, Hutyra Martin, Kozák Jirí, Lukl Jan, Táborský Milos

出版信息

Am J Hematol. 2010 Apr;85(4):296-9. doi: 10.1002/ajh.21635.

DOI:10.1002/ajh.21635

PMID:20169542

Abstract

摘要

相似文献

Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.

Am J Hematol. 2010 Apr;85(4):296-9. doi: 10.1002/ajh.21635.

[Oncogene Fip1-likeL/PDGFRalpha as a target for imatinib in patients with hypereosinophilic syndrome and chronic eosinophilic leukemia. A novel look at pathogenesis and therapy].

Pol Arch Med Wewn. 2005 May;113(5):490-7.

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.

Haematologica. 2007 Sep;92(9):1173-9. doi: 10.3324/haematol.11420. Epub 2007 Aug 1.

[The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib].

Zhonghua Yi Xue Za Zhi. 2005 Feb 23;85(7):448-52.

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.

Haematologica. 2004 Feb;89(2):236-7.

Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.

Am J Hematol. 2014 Jan;89(1):115. doi: 10.1002/ajh.23588. Epub 2013 Oct 15.

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells.

Oncotarget. 2014 Nov 15;5(21):10407-20. doi: 10.18632/oncotarget.2090.

Imatinib-responsive hypereosinophilic syndrome.

Leuk Res. 2006 Aug;30(8):915-6. doi: 10.1016/j.leukres.2006.02.007. Epub 2006 Mar 13.

Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.

Med Oncol. 2012 Jun;29(2):1073-6. doi: 10.1007/s12032-011-9831-1. Epub 2011 Jan 22.

[Identification of clonal proliferation of T cell and FIP1L1-PDGFRalpha fusion gene in hypereosinophilic syndrome associated with lymphomatoid papulosis which showed rapid and complete response to the treatment with imatinib].

Nihon Naika Gakkai Zasshi. 2007 Dec 10;96(12):2794-7. doi: 10.2169/naika.96.2794.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.

作者信息

Václavík Jan, Szotkowski Tomás, Hutyra Martin, Kozák Jirí, Lukl Jan, Táborský Milos

出版信息

Am J Hematol. 2010 Apr;85(4):296-9. doi: 10.1002/ajh.21635.

DOI:10.1002/ajh.21635

PMID:20169542

Abstract

摘要